(FDA) has refused emergency authorization of ivermectin to treat the novel coronavirus, stating for months that “[m]ore testing is needed.”
Nevertheless, several medical experts testified to the benefits of the drug for COVID-19 patients at a hearing held by the Senate Homeland Security Committee last week. In an impassioned speech, Dr. Pierre Kory, an intensive care specialist from Wisconsin, spoke to what he called “the miraculous effectiveness of ivermectin.”

Kory is a founding member of Front Line Covid-19 Critical Care Alliance (FLCCC), “a group of highly published leaders in critical care” seeking to stop excessive mortality from COVID-19. FLCCC has developed a treatment regimen incorporating ivermectin, which the group claims has led to up to 83% lower-than-average COVID-19 death rates in hospitals that have applied it.

Ivermectin “basically obliterates transmission of this virus,” Dr. Kory told senators.

“It literally destroys the virus in most people within 48 hours,” agreed fellow panelist Dr. Jean-Jacques Rajter, whose peer-reviewed study found 60% fewer deaths among patients given the drug.

Click Here and scroll down to watch Dr. Kory’s video report on Ivermectin

“I’ve been treating COVID pretty much every single day since the onset,” Kory said. “When I say miracle I do not use that term lightly. … That is a scientific recommendation based on mountains of data that has emerged in the last three months.”

Kory pointed to multiple randomized trials awaiting peer review, which he and nine FLCCC colleagues highlight in a pre-print manuscript.

For example, a recent trial of 400 COVID-19 patients from Egypt found nearly 100% improvement in test groups treated with ivermectin. The anti-parasite drug also “significantly reduced the incidence of infection in health care and household contacts up to 2% compared to 10% in non ivermectin group,” according to the study.

Kory and his colleagues also note published observation trials from Argentina demonstrating a nonexistent rate of COVID-19 contraction among people given ivermectin preventively. The lead researcher for the studies, Dr. Héctor Carvallo, explained in an interview that “out [of] the 788 who received” an ivermectin regimen, “not a single one got infected.” Conversely, “almost over half, over 50 percent … got infected” from the control group, he said.

Carvallo added that “by now half of Argentina is using” ivermectin, as are doctors in at least ten other South American countries…

Continue reading here.